Resveratrol Mitigates Cognitive Impairments and Cholinergic Cell Loss in the Medial Septum in a Mouse Model of Gradual Cerebral Hypoperfusion

• Main Authors: Eric Fagerli (Author), Charles W. Jackson (Author), Iris Escobar (Author), Fernando J. Ferrier (Author), Efrain J. Perez Lao (Author), Isabel Saul (Author), Jorge Gomez (Author), Kunjan R. Dave (Author), Oliver Bracko (Author), Miguel A. Perez-Pinzon (Author)
• Format: Book
• Published: MDPI AG, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Vascular cognitive impairment and dementia (VCID) is the second leading cause of dementia. There is currently no effective treatment for VCID. Resveratrol (RSV) is considered an antioxidant; however, our group has observed pleiotropic effects in stroke paradigms, suggesting more effects may contribu...